Effect of screening mammography on breast-cancer mortality in Norway

New England Journal of Medicine

Volumn 363, Issue 13, 2010, Pages 1203-1210

  Kalager, Mette ^a,b   Zelen, Marvin ^b,c   Langmark, Frøydis ^a   Adami, Hans Olov ^a,b,c,d  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NORWAY; PRIORITY JOURNAL; BREAST NEOPLASMS; COMPARATIVE STUDY; EPIDEMIOLOGY; MASS SCREENING; MIDDLE AGED; MORTALITY; RADIOGRAPHY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NORWAY; YOUNG ADULT;

EID: 77957147576     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1000727     Document Type: Article

References (26)

1. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988;80:1125-32.
2. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992;147:1477-88. [Erratum, CMAJ 1993;148:718.]
3. Nyström L, Rutqvist LE, Walls S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-8. [Erratum, Lancet 1993;342:1372.] (Pubitemid 23109165)
4. Vainio H, Bianchini F, eds. IARC handbook of cancer prevention. Vol 7. Breast cancer screening. Lyon, France: IARC Press, 2002.
5. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006;4:CD001877.
6. Nyström L. How effective is screening for breast cancer? BMJ 2000;321:647-8.
7. Berry DA, Corin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92.
8. Consumer report 4/2002. Oslo: The Consumer Council of Norway. (In Norwegian.) (Accessed August 30, 2010, at http://forbrukerportalen.no/ filearchive/4-2002-s-1-48.pdf.)
9. Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-31.
10. Tingulstad S, Haldorsen T, Norstein J, Hagen B, Skjeldestad FE. Completeness and accuracy of registration of ovarian cancer in the Cancer Registry of Norway. Int J Cancer 2002;98:907-11.
11. Kalager M, Haldorsen T, Bretthauer M, Hoff G, Thoresen SO, Adami HO. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 2009;11:R44.
12. Perry N, Broeders M, de Wolf C. European guidelines for quality assurance in breast cancer screening and diagnosis. 2nd ed. Luxembourg: Office for Official Publications of the European Communities, 1996.
13. Erzaas A. Quality assurance manual of the Norwegian Breast Cancer Screening Program. Oslo: The Cancer Registry of Norway, 2003. (In Norwegian.) (Available at http://www.kreftregisteret.no.)
14. Wang H, Kåresen R, Hervik A, Thoresen S. Mammography screening in Norway: results from the first screening round in four counties and cost effectiveness of a modeled nationwide screening. Cancer Causes Control 2001;12:39-45. (Pubitemid 32140393)
15. Kalager M, Kåresen R, Wist E. Survival after breast cancer - differences between Norwegian counties. Tidsskr Nor Laegeforen 2009;129:2595-600. (In Norwegian.)
16. Statistics Norway home page. (Accessed August 30, 2010, at http://statbank.ssb.no/statistikkbanken/Default-FR.asp?PXSid=0&nvl= true&PLanguage=0&tilside=selecttable/MenuSelS.asp&SubjectCode=02.)
17. The Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45-51.
18. Tabar L, Duffy SW, Yen MF, et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J Med Screen 2002;9:159-62.
19. Hakama M, Pukkala E, Heikkilä M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 1997;314:864-7. (Pubitemid 27182019)
20. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet 2002;359:909-19. [Erratum, Lancet 2002;360:724.]
21. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000;321:665-9.
22. Olsen AH, Njor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005;330:220.
23. Tabar L, Yen MF, Vitak B, Chen HHT, Smith R, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:1405-10. (Pubitemid 36515039)
24. Otto SJ, Fracherboud J, Looman CWN, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-7.
25. Jonsson H, Nyström L, Törnberg S, Lenner P. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality of breast cancer. J Med Screen 2001;8:152-60.
26. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.